Vis enkel innførsel

dc.contributor.authorSandvik, Reidun Karinen_US
dc.contributor.authorSelbæk, Geiren_US
dc.contributor.authorSeifert, Reinharden_US
dc.contributor.authorAarsland, Dagen_US
dc.contributor.authorBallard, Cliveen_US
dc.contributor.authorCorbett, Anneen_US
dc.contributor.authorHusebø, Bettina Sandgatheen_US
dc.date.accessioned2014-12-08T13:05:18Zen_US
dc.date.accessioned2014-12-09T08:36:11Zen_US
dc.date.accessioned2014-12-10T10:35:49Z
dc.date.available2014-12-10T10:35:49Z
dc.date.issued2014-05-13eng
dc.identifier.issn1090-3801
dc.identifier.urihttps://hdl.handle.net/1956/8884
dc.description.abstractBackground: Pain is frequent and distressing in people with dementia, but no randomized controlled trials have evaluated the effect of analgesic treatment on pain intensity as a key outcome. Methods: Three hundred fifty-two people with dementia and significant agitation from 60 nursing home units were included in this study. These units, representing 18 nursing homes in western Norway, were randomized to a stepwise protocol of treating pain (SPTP) or usual care. The SPTP group received acetaminophen, morphine, buprenorphine transdermal patch and pregabalin for 8 weeks, with a 4-week washout period. Medications were governed by the SPTP and each participant’s existing prescriptions. We obtained pain intensity scores from 327 patients (intervention n = 164, control n = 163) at five time points assessed by the primary outcome measure, Mobilization-Observation-Behaviour- Intensity-Dementia-2 (MOBID-2) Pain Scale. The secondary outcome was activities of daily living (ADL). We used a linear intercept mixed model in a two-way repeated measures configuration to assess change over time and between groups. Results: The SPTP conferred significant benefit in MOBID-2 scores compared with the control group [average treatment effect (ATE) −1.388; p < 0.001] at week 8, and MOBID-2 scores worsened during the washout period (ATE = −0.701; p = 0.022). Examining different analgesic treatments, benefit was conferred to patients receiving acetaminophen compared with the controls at week 2 (ATE = −0.663; p = 0.010), continuing to increase until week 8 (ATE = −1.297; p < 0.001). Although there were no overall improvements in ADL, an increase was seen in the group receiving acetaminophen (ATE = +1.0; p = 0.022). Conclusion: Pain medication significantly improved pain in the intervention group, with indications that acetaminophen also improved ADL function.en_US
dc.language.isoengeng
dc.publisherWileyeng
dc.rightsAttribution-NonCommercial-NoDerivs CC BY-NC-NDeng
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/eng
dc.titleImpact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: A cluster randomized trialen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2014-12-08T13:05:18Zen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2014 The Authors
dc.identifier.doihttps://doi.org/10.1002/ejp.523
dc.identifier.cristin1172014
dc.source.journalEuropean Journal of Pain
dc.source.4018
dc.source.1410
dc.source.pagenumber1490-1500


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivs CC BY-NC-ND
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivs CC BY-NC-ND